Recent

% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • hcorrao1@gmail.com hcorrao1 Feb 11, 2013 11:28 AM Flag

    Legit concerns ?

    I think the cash balance is a concern . Enough for Nuedetra to turn break even but not enough to carry clinical trials. Hoping for EU approval with some up front cash of 50 to 100 million . should be more but depends on reinbursements and possible labling restrictions.
    No I am not a pretend long , so give it a break. Just trying to have an intelligent conversation about the short term prospects.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I actually think the stars are lining up perfectly here for AVNR.........cash is a minor but growing concern. When EU approval and a partner / joint venture shows up (before end of '13) we will get up front $$ to tide us over until N becomes profitable and can support all other research.

      Just my opinion..........Kel

    • "No I am not a pretend long , so give it a break. Just trying to have an intelligent conversation about the short term prospects."

      LOL....Good luck with that. You soon figure out there are large number of over-invested starry eyed pumpers here that will attack you for expressing any kind of concern or attempt at trying to understand why the launch and uptake of N has SUCKED. They will resort to lying - like the latest post from frustrated pumper extraordinaire - mikie24 - who accuses me of posting 100's of times per week. A quick review of my posting history quickly reveals yet another lie about me.

      Enjoy your beating.

      Sentiment: Strong Sell

 
AVNR
16.960.00(0.00%)Jan 12 4:00 PMEST